TELA Bio, Inc.
TELA
$0.9596
-$0.0124-1.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.83% | 25.94% | 11.02% | 39.42% | 46.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.83% | 25.94% | 11.02% | 39.42% | 46.26% |
| Cost of Revenue | 19.97% | 31.44% | 17.27% | 32.07% | 57.54% |
| Gross Profit | -3.44% | 23.55% | 8.47% | 43.01% | 41.69% |
| SG&A Expenses | -17.30% | 10.73% | 12.58% | 24.85% | 42.50% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.18% | 12.24% | 11.29% | 25.24% | 39.01% |
| Operating Income | 31.96% | 8.01% | -11.66% | -10.24% | -30.08% |
| Income Before Tax | 27.45% | 5.34% | -16.77% | 52.93% | -29.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.56% | 5.34% | -16.77% | 52.93% | -29.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.56% | 5.34% | -16.77% | 52.93% | -29.17% |
| EBIT | 31.96% | 8.01% | -11.66% | -10.24% | -30.08% |
| EBITDA | 33.25% | 8.64% | -11.56% | -10.26% | -31.25% |
| EPS Basic | 56.34% | 6.17% | -10.04% | 63.26% | -1.06% |
| Normalized Basic EPS | 55.65% | 6.19% | -10.03% | 14.06% | -1.08% |
| EPS Diluted | 56.34% | 6.17% | -10.04% | 63.44% | -1.06% |
| Normalized Diluted EPS | 55.65% | 6.19% | -10.03% | 14.06% | -1.08% |
| Average Basic Shares Outstanding | 63.64% | 0.90% | 6.13% | 28.11% | 27.82% |
| Average Diluted Shares Outstanding | 63.64% | 0.90% | 6.13% | 28.11% | 27.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |